Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosol Inhalation Treatment for Dyspnea
NCT01440764Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Sep 2011
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in Dyspnea, sponsored by Beth Israel Deaconess Medical Center. Started Sep 2011; status: completed.
02
Drugs
furosemide
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT01440764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01440764.